262444-42-8

Basic information

• Product Name: tert-butyl-2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-ioxaborolan-2-yl)phenylcarbamate
• Synonyms: tert-butyl-2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-ioxaborolan-2-yl)phenylcarbamate;4-(BOC-amino)-3-fluorophenylboronic acid,pinacol;N-Boc-4-amino-3-fluorophenylboronic Acid Pinacol Ester;N-Boc-4-amino-3-fluorophenylboronic acid pi;4-(BOC-amino)-3-fluorophenyl boronic acid, pinacol ester;t-Butyl 2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenylcarbamate;N-tert-butyl-N-[2-fluoro-4-(tetraMethyl-1,3,2-dioxaborolan-2-yl)phenyl]carbaMate;tert-butyl N-[2-fluoro-4-(tetraMethyl-1,3,2- dioxaborolan-2-yl)phenyl]carbaMate
• CAS NO: 262444-42-8
• Molecular Formula: C₁₇H₂₅BFNO₄
• Molecular Weight: 337.197
• Mol File: 262444-42-8.mol

Chemical Properties

• Boiling Point: 376.622 °C at 760 mmHg
• Flash Point: 181.575 °C
• Appearance: /
• Density: 1.11
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.496
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 12.91±0.70(Predicted)
• CAS DataBase Reference: tert-butyl-2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-ioxaborolan-2-yl)phenylcarbamate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl-2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-ioxaborolan-2-yl)phenylcarbamate(262444-42-8)
• EPA Substance Registry System: tert-butyl-2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-ioxaborolan-2-yl)phenylcarbamate(262444-42-8)

Safety Data

• Hazardous Substances Data: 262444-42-8(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Tert-butyl-2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-ioxaborolan-2-yl)phenylcarbamate serves as a versatile building block for the synthesis of various biologically active compounds. Its unique structure and reactivity contribute to the development of new pharmaceutical agents, enhancing drug discovery and medicinal chemistry research.
Used in Agrochemical Industry:
Similarly, in the agrochemical sector, this compound is utilized as a key intermediate in the synthesis of bioactive molecules for crop protection and pest control. Its properties allow for the creation of innovative agrochemicals that can improve agricultural productivity and sustainability.
Used in Medicinal Chemistry Research:
Tert-butyl-2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-ioxaborolan-2-yl)phenylcarbamate is employed as a research tool in medicinal chemistry. Its distinctive structural features and reactivity make it suitable for exploring new chemical spaces and designing novel therapeutic agents with potential applications in treating various diseases.
Used in Drug Discovery:
In the realm of drug discovery, this compound plays a crucial role as a synthetic intermediate. Its incorporation into the development pipeline allows researchers to create diverse libraries of compounds, which can be screened for potential drug candidates, thereby accelerating the process of identifying new therapeutics.

InChI:InChI=1/C17H25BFNO4/c1-15(2,3)22-14(21)20-13-9-8-11(10-12(13)19)18-23-16(4,5)17(6,7)24-18/h8-10H,1-7H3,(H,20,21)

Upstream product

• 209958-42-9 tert-butyl N-(4-bromo-2-fluorophenyl)carbamate 
• 24424-99-5 di-tert-butyl dicarbonate 
• 367-24-8 4-bromo-2-fluoroaniline 
• 76-09-5 2,3-dimethyl-2,3-butane diol 
• 218301-87-2 4-(tert-butoxycarbonylamino)-3-fluorophenylboronic acid 

Downstream Products

• 330793-36-7 ethyl 2-(4-amino-3-4-[(tert-butoxycarbonyl)amino]-3-fluorophenyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)acetate 
• 819058-34-9 2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline 
• 939807-38-2 ethyl 4-{4-[(tertbutoxycarbonylamino)]-3-fluorophenyl}-5-cyano-1-{[2-(trimethylsiIyl)ethoxy]methyl}-1H-pyrrole-3-carboxylate 
• 939967-96-1 tert-butyl {4-[4-amino-7-(morpholin-4-ylmethyl)pyrrolo[2,1-f][1,2,4]triazin-5-yl]-2-fluorophenyl}carbamate 

Relevant articles and documents

Substituted sulphoximines as Tie2 inhibitors and salts thereof, pharmaceutical compositions comprising the same, methods of preparing the same and uses of the same

The invention relates to substituted sulphoximines according to the general formula (I): in which A, E, G, X, R1, R2, R3, R4, R5, R6, R7, R8, m, p, q, are given in the

SULFONAMIDO-MACROCYCLES AS TIE2 INHIBITORS AND SALTS THEREOF, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, METHODS OF PREPARING SAME AND USES OF SAME

The invention relates to sulfonamido-macrocycles according to the general formula (I): in which R1, R2, R4, R5, R6, A, B, C, L, X, Y, Z, n, and m are as defined in the claims, and salts, N-oxides, or

SUBSTITUTED 4-AMINO-PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS

This invention relates to novel pyrrozolotriazine compounds, pharmaceutical compositions containing such compounds and and the use of those compounds or compositions for treating hyper-proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients.

Pyrazolopyrimidines as therapeutic agents

The present invention is directed to pyrazolopyrimidine derivatives of formula (I) wherein the substituents are defined herein, which are useful as kinase inhibitors and as such are useful for affecting angiogenesis and diseases and conditions associated with angiogenesis.

Pyrrolopyrimidines as therapeutic agents

Chemical compounds having structural formula I and physiologically acceptable salts and metabolites thereof, are inhibitors of serine/threonine and tyrosine kinase activity. Several of the kinases, whose activity is inhibited by these chemical compounds, are involved in immunologic, hyperproliferative, or angiogenic processes. Thus, these chemical compounds can ameliorate disease states where angiogenesis or endothelial cell hyperproliferation is a factor. These compounds can be used to treat cancer and hyper proliferative disorders, rheumatiod arthritis, disorders of the immune system, trasplant refections and imflammatory disorders.

Pyrazolopyrimidines as therapeutic agents

The present invention provides compounds of Formula I, including pharmaceutically acceptable salts and/or prodrugs thereof, where G, R2, and R3 are defined as described herein.